「Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model」の関連論文
-
Automated measurement of fluorescence signals reveals a significant increase of the graft-derived neurite extension in neonates compared to aged rats
-
Studies on Coriandrum sativum affectingcancer metastasis and the actionmechanism
-
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma
-
Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase
-
In silico study of RNA-seq and H3 Trimethylation ChIP-seq analysis in combination with laser-microdissection on human lung cancer cells
-
RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence
-
Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation
-
Novel and efficient method for culturing patient-derived gastric cancer stem cells
-
Cancer-specific targeting of taurine upregulated gene 1 enhances the effects of chemotherapy in pancreatic cancer
-
Development of optical platforms for elucidating the intracellular molecular mechanisms and immune cell dynamics induced by multispectral near infrared laser (本文)
-
Correlations of high molecular weight adiponectin, tumor necrosis factor-alpha and vascular endothelial growth factors with occurrence of colonic polyps in the prediabetic population
-
2-nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche (本文)
-
Design of Novel Targeted Co-delivery System for Combined Chemotherapy and Gene Therapy of Hepatocellular Carcinoma [an abstract of entire text]
-
The effect of gemcitabine on cell cycle arrest and microRNA signatures in pancreatic cancer cells
-
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
-
Establishment of a radiation-induced vocal fold fibrosis mouse model
-
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer
-
Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice (本文)
-
Expansion of gastric intestinal metaplasia with copy number aberrations contributes to field cancerization
-
Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy
-
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
-
Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase
-
Deletion of IKKβ in activated fibroblasts promotes tumor progression in melanoma
-
Basis research and development of DNA-targeted radio-platinum agents for Auger electron cancer therapy
-
Inhibition of VEGF receptors induces pituitary apoplexy: an experimental study in mice
-
Project 1 Analyzing Tumor Microenvironment and Exploiting its Characteristics in Search of Optimizing Cancer Therapy Including Neutron Capture Therapy (R2P1)
-
Functional and genomic characterization of patient-derived xenograft model to study adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma
-
Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids
-
JNK pathway plays a critical role for expansion of human colorectal cancer in the context of BRG1 suppression
-
Survival benefit of surgery for very elderly patients with pancreatic cancer : what extent of pancreatectomy is acceptable?
-
Utility of magnetic resonance imaging in pancreatic ductal adenocarcinoma evaluation
-
A drug repurposing study based on clinical big data for the protective role of vitamin D in olanzapine-induced dyslipidemia
-
An Integrated In Silico and In Vivo Approach to Identify Protective Effects of Palonosetron in Cisplatin-Induced Nephrotoxicity
-
Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
-
Oncolytic HSV-1 in combination with lenalidomide for plasma cell neoplasms
-
Evolutionary histories of breast cancer and related clones
-
Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer
-
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism
-
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
-
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
-
Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1
-
Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1
-
Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody
-
Genomic analysis for the prediction of prognosis in small-bowel cancer
-
Genomic analysis for the prediction of prognosis in small-bowel cancer
-
Propofol elicits apoptosis and attenuates cell growth in esophageal cancer cell lines
-
Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer